2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

ASCO® 2024 Insights: "MIST5 Trial - Niraparib & Dostarlimab in Platinum-Sensitive Relapsed Mesothelioma"

96 views
June 6, 2024
0 Comments
Login to view comments. Click here to Login
Lung